Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Sio Gene Therapies Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −3 vs. Q2 2022
- Shares held
- 21.1M
- +434.7K (+2.1%) vs. Q2 2022
- Total value
- $5.91M
- −$1.53M (−20.6%) vs. Q2 2022
- New holders
- 1
- 9 more added
- Sold out
- 4
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SIOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $26.0K |
| Q1 2023 | 4 | $1.13M |
| Q4 2022 | 37 | $8.09M |
| Q3 2022 | 38 | $5.91M |
| Q2 2022 | 41 | $7.44M |
| Q1 2022 | 40 | $12.1M |
| Q4 2021 | 48 | $27.6M |
| Q3 2021 | 55 | $39.9M |
| Q2 2021 | 53 | $56.1M |
| Q1 2021 | 55 | $53.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Sio Gene Therapies Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fifth Third Bancorp | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 114 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 362 | $0 | 0.00% | +2+0.6% | Added |
| The PNC Financial Services Group, Inc. | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 902 | $0 | 0.00% | −14−1.5% | Reduced |
| Simplex Trading, LLC | 316 | $0 | 0.00% | +279+754.1% | Added |
| Hudock, Inc. | 179 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 400 | $0 | 0.00% | −300−42.9% | Reduced |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,527 | $1.00K | 0.00% | −51,002−91.8% | Reduced |
| Capital Advisors, Ltd. LLC | 1,992 | $1.00K | 0.00% | +687+52.6% | Added |
| Wolff Wiese Magana LLC | 2,400 | $1.00K | 0.00% | +2,000+500.0% | Added |
| Primecap Management Co | 15,600 | $4.00K | 0.00% | −1,100−6.6% | Reduced |
| Morgan Stanley | 12,380 | $4.00K | 0.00% | −10.0% | Reduced |
| Merit Financial Group, LLC | 17,750 | $5.00K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 20,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 30,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 38,306 | $11.0K | 0.00% | +3,292+9.4% | Added |
| Franklin Resources Inc | 55,570 | $16.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 64,170 | $18.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 70,925 | $20.0K | 0.00% | −100−0.1% | Reduced |
| Northern Trust Corp | 87,153 | $24.0K | 0.00% | 00.0% | Unchanged |
| Boston Private Wealth LLC | 94,150 | $26.0K | 0.00% | +94,150 | New |
| Jane Street Group, LLC | 99,324 | $28.0K | 0.00% | +6,879+7.4% | Added |
| Bridgeway Capital Management, LLC | 105,400 | $30.0K | 0.00% | −50,000−32.2% | Reduced |
| ACT Capital Management, LLC | 146,500 | $41.0K | 0.06% | 00.0% | Unchanged |
| State Street Corp | 173,621 | $49.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 362,000 | $101.0K | 0.00% | −98,394−21.4% | Reduced |
| BlackRock Inc. | 390,393 | $109.0K | 0.00% | +70.0% | Added |
| Clearline Capital LP | 392,691 | $110.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 433,386 | $121.0K | 0.00% | 00.0% | Unchanged |
| Cladis Investment Advisory, LLC | 552,000 | $154.6K | 0.17% | −185,000−25.1% | Reduced |
| Newtyn Management, LLC | 1,500,000 | $420.0K | 0.09% | +84,141+5.9% | Added |
| Hudson Bay Capital Management LP | 1,680,536 | $471.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,840,707 | $516.0K | 0.00% | −257,874−12.3% | Reduced |
| Suvretta Capital Management, LLC | 5,914,000 | $1.66M | 0.07% | 00.0% | Unchanged |
| Rubric Capital Management LP | 7,000,000 | $1.96M | 0.10% | +988,995+16.5% | Added |
| Tower View Investment Management & Research LLC | 11,645 | – | – | −8−0.1% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −57,187−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −23,028−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −20,749−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,018−100.0% | Sold out |